Asian stocks outside Japan fell as stronger growth in U.S. service industries fueled speculation the Federal Reserve will soon reduce economic stimulus.
HSBC Holdings Plc (5) slumped 5 percent in Hong Kong after earnings at Europe�� biggest bank missed estimates. Sony Corp. (6758) slid 4.6 percent in Tokyo after its board rejected billionaire Daniel Loeb�� call to spin off part of its entertainment business. Fonterra Shareholders Fund climbed 1.3 percent in New Zealand, recouping some of yesterday�� record decline after China and Russia halted imports of milk powder from Fonterra Cooperative Group Ltd., the world�� largest dairy exporter.
The MSCI Asia Pacific excluding Japan Index retreated 0.5 percent to 440.98 at 8:18 p.m. in Hong Kong, as more than two stocks fell for every one that rose.
��he ramp-up in the U.S. economy is not only gaining momentum, but is accelerating,��Evan Lucas, a Melbourne-based market strategist at IG Markets Ltd., a provider of trading services for equities, currencies and commodities, said by e-mail. ��his is increasing the hawkish view of the Fed. This is why the September taper talk will continue. The blueprint for monetary stimulus tapering will be laid out in September with the first wind-back in October.��
Top 5 Prefered Companies To Buy For 2015: Le Gaga Holdings Limited (GAGA)
Le Gaga Holdings Limited engages in cultivating, processing, and distributing vegetables, fruits, and tea leaves in the People�s Republic of China and Hong Kong. The company is also involved in cultivating and selling fir trees. It offers solanaceous vegetables, including sweet peppers, tomatoes, eggplants, pumpkins, and cucumbers; leafy vegetables comprising flowering Chinese cabbage, baby bok choy, and baby Chinese cabbage; and cruciferous vegetables, such as broccoli and Chinese cabbage. As of March 31, 2012, the company operated 11 farms with an aggregate area of 1,671 hectares in Fujian, Guangdong, and Hebei provinces. It sells approximately 50 varieties of vegetables primarily to wholesalers, institutional customers, and supermarket chains. The company was founded in 2004 and is based in Kowloon, Hong Kong.Advisors' Opinion:
- [By Monica Gerson]
Le Gaga Holdings (NASDAQ: GAGA) is estimated to report its Q4 earnings.
Adobe Systems (NASDAQ: ADBE) is expected to post its Q3 earnings at $0.34 per share on revenue of $1.01 billion.
Hot Heal Care Stocks To Watch Right Now: TAL International Group Inc.(TAL)
TAL International Group, Inc. engages in the lease of intermodal containers and chassis. It operates in two segments, Equipment Leasing and Equipment Trading. The Equipment Leasing segment involves in the acquisition, lease, re-lease, and sale of various intermodal transportation equipment, such as dry freight containers, which are used for general cargo, including manufactured component parts, consumer staples, electronics, and apparel; refrigerated containers that are used for perishable items, such as fresh and frozen foods; and special containers, which are used for heavy and oversized cargo, such as marble slabs, building products, and machinery. It also leases chassis, which are used for the transportation of containers and tank containers that are used to transport bulk liquid products, such as chemicals, as well as finances port equipment, which includes container cranes, reach stackers, and other related equipment. The Equipment Trading segment purchases container s from shipping line customers and other sellers of containers, and resells these containers to container traders and users of containers for storage or one-way shipment. As of December 31, 2009, it had a fleet of 701,946 containers and chassis, including 31,137 containers under management for third parties, representing 1,139,523 twenty-foot equivalent units (TEU). The company was founded in 1963 and is headquartered in Purchase, New York.Advisors' Opinion:
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, freight container lessor TAL International (NYSE: TAL ) has earned a coveted five-star ranking.
- [By ABN]
TAL International Group (TAL) is one of the world's largest lessors of intermodal freight containers for the shipping business with 17 offices in 11 countries and approximately 230 third-party container depot facilities in 40 countries. TAL's fleet consists of approximately 1,238,000 containers and 2,031,000 twenty-foot equivalent units (TEU).
Hot Heal Care Stocks To Watch Right Now: Intercept Pharmaceuticals Inc (ICPT)
Intercept Pharmaceuticals, Inc., incorporated on September 4, 2002, is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver diseases utilizing its bile acid chemistry.The Company�� product candidates treat orphan and more prevalent liver diseases for which there are limited therapeutic solutions. The Company�� product candidate, obeticholic acid, or OCA, is a bile acid analog, a chemical substance that has a structure based on a naturally occurring human bile acid. It is developing OCA initially for primary biliary cirrhosis, or PBC, as a second line treatment for patients who have an inadequate response to or who are unable to tolerate standard of care therapy and therefore need additional treatment. The Company is conducting a Phase 3 clinical trial of OCA in PBC, which it calls the POISE trial, that serves as the basis for seeking regulatory approval in the United States and Europe. As of December 19, 2012, the Company completed enrollment of the POISE trial with 217 patients.
The Company�� clinical focus is on the development of OCA, orally administered, first-in-class FXR agonist that has broad liver-protective properties and may a variety of chronic insults to the liver that cause fibrosis, which can eventually lead to cirrhosis, liver transplant and death. The Company owns worldwide rights to OCA outside of Japan and China, where it has licensed the compound to Dainippon Sumitomo Pharma, or DSP, and granted it an option to license OCA in certain other Asian countries.The Company is sponsoring an independent study involving more than ten leading PBC centers in North America and Europe, or collectively the Global PBC Study Group, that are pooling their long-term patient data to evaluate the relationship between biochemical and clinical endpoints.
The Company competes with Eli Lilly, Exelixis, Inc., Phenex Pharmaceuticals AG, , Johnson & Johnson, NovImmune SA, Dr. Falk Pharma GmbH, Galmed Medical Researc! h Ltd., Immuron Ltd., Mochida Pharmaceutical Co., Ltd., NasVax Ltd. , Raptor Pharmaceutical Corp. Astellas Pharma US, Inc., AstraZeneca, Salix Pharmaceuticals, Inc. and Tioga Pharmaceuticals, Inc.Advisors' Opinion:
- [By Ben Levisohn]
It’s hard not to think it might be. Today, Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), Celgene (CELG), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX).
- [By Ben Levisohn]
Sure Intercept Pharmaceuticals (ICPT) might feel like the only biotech stock that matters today, but there are others. For instance, Incyte (INCY) and� BioMarin (BMRN) are on the move after Barclays changed its ratings on the pair.REUTERS
But before getting into that, let’s talk about Barclays’ Ying Huang and team’s thoughts on the sector. Would you believe they echo those of Goldman Sachs in its downgrade of the sector earlier this week (and just about everyone else) by calling this a stock picker’s market?
Biotech should continue to outperform in 2014, but may be a more stock-specific year: We believe biotech as a group will continue to outperform the broad market in 2014 but do not expect a repeat of 2013. In 2013, the Nasdaq Biotech Index outperformed the S&P 500 by a large margin (+65.6% vs. S&P +29.6%), driven by a combination of generalist investor interest, hunt for growth opportunities, healthy long-term outlook for the industry, and an accommodative FDA. While we expect trends to remain strong in the overall industry and for biotech to outperform the broader market in 2014, it will likely be more muted, with fewer meaningful catalysts and as investors favor larger companies with less downside risk.
Huang too falls back on the PEG ratio–Price/Earnings to Growth–while explaining away the sectors P/E of 31.4, which dwarfs the 18 P/E in U.S. pharmaceuticals. “Looking at PEG ratios, which we view as a more appropriate metric given the growth profile of biotech companies, the group has traded at a reasonable and stable 1.0x for the past decade,” Huang says.
As for Incyte and BioMarin, Huang explains why he’s bullish on the former, bearish on the latter:
After taking a closer look at [Incyte's] pipeline assets, we are increasingly bullish on its proprietary JAK1 inhibitor INCB39110 and its IDO inhibitor INCB024360 and have increased ou
- [By Sue Chang and Ben Eisen]
Shares of Intercept Pharmaceuticals Inc. (ICPT) �soared another 62% following a surge of 281% on Thursday. The company announced on Thursday that halted the trial of its obeticholic acid drug to treat nonalcoholic steatohepatitis (NASH) ahead of schedule on positive results. The drug could be the first reliable treatment option for patients facing liver transparent and as a result, obeticholic acid could be a true blockbuster, according to Jim Molloy, an analyst at Janney Capital Markets.
Hot Heal Care Stocks To Watch Right Now: Village Super Market Inc.(VLGEA)
Village Super Market, Inc., together with its subsidiaries, operates a chain of supermarkets in the United States. The company?s superstores feature specialty departments, such as home meal replacement, on-site bakery, and expanded delicatessen that includes prepared food, natural and organic food, ethnic and international food, seafood sections, as well as pharmacies and salad bars. Its superstores also offer non-food items, including cut flowers, health and beauty aids, greeting cards, and small appliances. As of December 16, 2011, the company operated a chain of 28 supermarkets under the ShopRite name in New Jersey, Maryland, and eastern Pennsylvania. Village Super Market, Inc. was founded in 1933 and is based in Springfield, New Jersey.Advisors' Opinion:
- [By Geoff Gannon]
Next example: same year (2000), same state (New Jersey), same product (food), different company ��Village Supermarket (VLGEA).
At the time, these were the company�� last five years of (diluted) earnings per share:
- [By Geoff Gannon] strong>J&J Snack Foods (JJSF)
Check out the performance numbers on those three stocks over the last 10-13 years (I bought them at different times). You��l notice that if I just never sold those stocks I wouldn�� need to do anything else. Those three stocks would��e made a fine portfolio for the next decade or so.
Well, I did sell those stocks. And I did a lot else. And some of it worked very well and some of it worked very badly. But, almost without fail, the net result was never better than what would have happened if I�� kept those three stocks.
That�� not an accident. It took me a very, very long time to buy stocks when I was a kid. I bought six stocks in my first five years as an investor. That�� not quite a 20 punches approach ��but it�� pretty close.
Why did I only buy one stock a year?
Because I didn�� know anything about stocks. And I didn�� think I knew anything about stocks.
My investment style was formed from a combination of extreme ignorance and extreme confidence. I was totally ignorant about stocks. And I was totally confident that I could learn all I needed to know about the stocks I needed to know about.
That combination led to focusing on a few very specific stocks. Stocks I was comfortable with.
When I was 14, there were only two places my money went. Into my brokerage account. Or into video games. So it�� not a surprise I bought Activision. At the time the video game industry had a much clearer future than it does today. And there was no better CEO of a video game company than Bobby Kotick. The balance sheet was pristine. When you backed out cash, the stock was cheap relative to sales. I looked at everything I could about video game companies and I decided sales were pretty profitable and pretty cash generative in this industry. All you needed was sensible capital allocation. All you needed was management that was going to run the place like a business. And I thought you h
- [By Geoff Gannon]
Line up the return on capital lines ��for the last 10 years ��for Arden, Village (VLGEA), Weis, Harris Teeter (HTSI), and Kroger and you��l see that the grocer this analyst thinks is unique clearly isn��. Other grocers earn their cost of capital. They just aren�� as well known.
- [By Geoff Gannon] the last 10 years ��population growth, inflation, and real output per person growth has been so low it�� hard to tell the difference between companies growing at the rate of inflation, along with the population, or along with the economy.
You have to squint really hard to see any difference in the revenue growth records of DNB, Chuck E. Cheese, and Village.
This will not be true in all countries and at all times.
A literally no growth company like Earthlink is actually shrinking. It just happens to look like it�� staying perfectly flat because inflation is hiding the company�� real decay rate. In real terms, the company has been shrinking by about 3% a year for the last 10 years. So, Earthlink is not a no growth company. It�� shrinking.
That�� a bad sign. And, frankly, I don�� know how to value Earthlink. You would need to evaluate it as a turnaround or something ��not as a business that�� simplly stuck in place. I don�� know how to do that.
So, Earhtlink goes into the ��oo hard��pile.
Dun & Bradstreet and CEC Entertainment are actual no growth businesses. This is hidden by their constant share buy backs. So, if you look at their earnings per share growth they look kind of like Peter Lynch�� idea of a ��low growth��company or even a ��talwart�� They aren��. They��e no growth businesses.
The same is pretty much true with Village Supermarket. Although this is complicated. The nature of their business ��high volume, low cost groceries ��means they can appear to be a no growth business when they are actually just keeping prices down and increasing volume. You would need to check their sales numbers more carefully. Grocery stores often discuss inflation in their annual reports. Village Supermarket always does this.
(The annual report is Exhibit 13 of the 10-K at EDGAR).
So, in reality, Village Supermarket may be a slow grower, while CEC Entertainment and Dun & Bradstreet